• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析技术失败及其对患者生存的影响。

Technique failure in peritoneal dialysis and its impact on patient survival.

作者信息

Woodrow G, Turney J H, Brownjohn A M

机构信息

Renal Unit, General Infirmary at Leeds, U.K.

出版信息

Perit Dial Int. 1997 Jul-Aug;17(4):360-4.

PMID:9284463
Abstract

OBJECTIVE

To determine the frequency and causes of continuous ambulatory peritoneal dialysis (CAPD) technique failure and its effect on patient outcome.

DESIGN

Retrospective study of CAPD technique and patient outcome.

SETTING

Teaching hospital renal unit.

PATIENTS

All 221 patients commencing CAPD over a 14-year period.

OUTCOME MEASURES

Outcomes assessed included patient survival and technique survival (with change to hemodialysis being considered as technique failure).

RESULTS

CAPD failure occurred in 46 patients, with a CAPD technique survival of 93%, 73%, and 63% at 1, 3, and 5 years after start of treatment. Peritonitis was the major cause of technique failure. CAPD system had no effect on technique survival, despite the lower peritonitis rate in patients using Y-connection systems. Overall patient survival was 91%, 72%, and 53% at 1, 3, and 5 years after start of treatment, with increasing age and diabetes being associated with a worse outcome. There was a high early mortality after CAPD failure, with an actuarial survival of only 61% 1 year later.

CONCLUSION

Failure of CAPD is an important problem, with peritonitis being the major cause, either directly, or indirectly by the later effects of damage to the peritoneal membrane with loss of dialysis adequacy. The high mortality in the period following CAPD failure warrants careful monitoring of patients during this phase, along with efforts to optimize correctable factors such as nutrition, adequacy of the new form of dialysis, and treatment of residual sepsis.

摘要

目的

确定持续性非卧床腹膜透析(CAPD)技术失败的频率、原因及其对患者预后的影响。

设计

对CAPD技术及患者预后的回顾性研究。

地点

教学医院肾脏科。

患者

14年间开始进行CAPD的所有221例患者。

观察指标

评估的结局包括患者生存率和技术生存率(将转为血液透析视为技术失败)。

结果

46例患者发生CAPD失败,治疗开始后1年、3年和5年的CAPD技术生存率分别为93%、73%和63%。腹膜炎是技术失败的主要原因。尽管使用Y型连接系统的患者腹膜炎发生率较低,但CAPD系统对技术生存率无影响。治疗开始后1年、3年和5年的总体患者生存率分别为91%、72%和53%,年龄增加和糖尿病与较差的预后相关。CAPD失败后早期死亡率较高,1年后精算生存率仅为61%。

结论

CAPD失败是一个重要问题,腹膜炎是主要原因,腹膜炎可直接导致技术失败,或因腹膜损伤的后期影响导致透析充分性丧失而间接导致技术失败。CAPD失败后期间的高死亡率需要在此阶段对患者进行密切监测,并努力优化可纠正因素,如营养、新透析形式的充分性以及残余脓毒症的治疗。

相似文献

1
Technique failure in peritoneal dialysis and its impact on patient survival.腹膜透析技术失败及其对患者生存的影响。
Perit Dial Int. 1997 Jul-Aug;17(4):360-4.
2
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.在墨西哥一家腹膜透析中心,与持续性非卧床腹膜透析相比,接受自动化腹膜透析治疗的患者其患者/技术生存率及腹膜炎发生率得到改善。
Kidney Int Suppl. 2008 Apr(108):S76-80. doi: 10.1038/sj.ki.5002606.
3
Outcome and complications in patients treated with continuous ambulatory peritoneal dialysis (CAPD) at a single centre during 11 years.11年间在单一中心接受持续性非卧床腹膜透析(CAPD)治疗的患者的治疗结果及并发症
Neth J Med. 1996 Jul;49(1):4-12. doi: 10.1016/0300-2977(96)00009-5.
4
Comparison of outcomes on continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis: results from a USA database.连续流动式腹膜透析与自动化腹膜透析的疗效比较:来自美国数据库的结果。
Perit Dial Int. 2011 Nov-Dec;31(6):679-84. doi: 10.3747/pdi.2010.00004. Epub 2010 Sep 9.
5
Current status of peritoneal dialysis in Korea: efforts to achieve optimal outcome.韩国腹膜透析的现状:为实现最佳治疗效果所做的努力。
Perit Dial Int. 1999;19 Suppl 3:S17-25.
6
Long-term outcomes in children on chronic continuous ambulatory peritoneal dialysis: a retrospective cohort study from a developing country.发展中国家长期接受慢性持续非卧床腹膜透析儿童的转归:一项回顾性队列研究。
Pediatr Nephrol. 2019 Nov;34(11):2389-2397. doi: 10.1007/s00467-019-04311-w. Epub 2019 Aug 29.
7
Relationship between uric acid and technique failure in patients on continuous ambulatory peritoneal dialysis: a long-term observational cohort study.尿酸与持续性不卧床腹膜透析患者技术失败的关系:一项长期观察性队列研究。
BMJ Open. 2017 Apr 7;7(4):e010816. doi: 10.1136/bmjopen-2015-010816.
8
Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.持续性非卧床腹膜透析患者生存的预测因素:德黑兰两大中心的10年经验
Iran J Kidney Dis. 2010 Jan;4(1):44-9.
9
Improving outcome of CAPD: twenty-five years' experience in a single Korean center.改善持续性非卧床腹膜透析的治疗效果:韩国单一中心的25年经验
Perit Dial Int. 2007 Jul-Aug;27(4):432-40.
10
The negative impact of early peritonitis on continuous ambulatory peritoneal dialysis patients.早期腹膜炎对持续性非卧床腹膜透析患者的负面影响。
Perit Dial Int. 2014 Sep-Oct;34(6):627-35. doi: 10.3747/pdi.2013.00024. Epub 2014 Feb 4.

引用本文的文献

1
Association between reduced left ventricular ejection fraction and peritoneal dialysis related peritonitis: a single center retrospective cohort study in Japan.左心室射血分数降低与腹膜透析相关性腹膜炎的关系:日本单中心回顾性队列研究。
Sci Rep. 2023 Dec 20;13(1):22697. doi: 10.1038/s41598-023-49744-4.
2
Optimal peritoneal fluid white blood cell count for diagnosis of peritonitis in peritoneal dialysis patients.腹膜透析患者诊断腹膜炎的最佳腹腔液白细胞计数
Kidney Res Clin Pract. 2023 Jan;42(1):127-137. doi: 10.23876/j.krcp.21.254. Epub 2022 Sep 14.
3
Case Report: Recurring Peritonitis and Dialysis Failure in a Toddler on Peritoneal Dialysis.
病例报告:一名接受腹膜透析的幼儿反复发生腹膜炎及透析失败
Front Pediatr. 2021 Mar 4;9:632915. doi: 10.3389/fped.2021.632915. eCollection 2021.
4
Novel Application of Magnetite Nanoparticle-Mediated Vitamin D3 Delivery for Peritoneal Dialysis-Related Peritoneal Damage.磁铁矿纳米颗粒介导的维生素D3递送在腹膜透析相关腹膜损伤中的新应用
Int J Nanomedicine. 2021 Mar 11;16:2137-2146. doi: 10.2147/IJN.S291001. eCollection 2021.
5
Surgical versus percutaneous catheter placement for peritoneal dialysis: an updated systematic review and meta-analysis.手术与经皮导管置管在腹膜透析中的应用:更新的系统评价和荟萃分析。
J Nephrol. 2021 Oct;34(5):1681-1696. doi: 10.1007/s40620-020-00896-w. Epub 2020 Nov 16.
6
The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage.维生素 D 纳米医学对腹膜透析相关腹膜损伤的临床意义。
Int J Nanomedicine. 2019 Dec 5;14:9665-9675. doi: 10.2147/IJN.S215717. eCollection 2019.
7
Viridans streptococcus peritonitis in peritoneal dialysis: clinical characteristics and comparison with concurrent polymicrobial infection.腹膜透析中的草绿色链球菌腹膜炎:临床特征及与并发多微生物感染的比较
BMC Nephrol. 2018 Oct 19;19(1):271. doi: 10.1186/s12882-018-1078-z.
8
Application of automated peritoneal dialysis in urgent-start peritoneal dialysis patients during the break-in period.自动化腹膜透析在紧急启动腹膜透析患者导入期的应用
Int Urol Nephrol. 2018 Mar;50(3):541-549. doi: 10.1007/s11255-018-1785-1. Epub 2018 Jan 16.
9
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.用于预防腹膜透析患者腹膜炎的抗菌药物。
Cochrane Database Syst Rev. 2017 Apr 8;4(4):CD004679. doi: 10.1002/14651858.CD004679.pub3.
10
Relationship between uric acid and technique failure in patients on continuous ambulatory peritoneal dialysis: a long-term observational cohort study.尿酸与持续性不卧床腹膜透析患者技术失败的关系:一项长期观察性队列研究。
BMJ Open. 2017 Apr 7;7(4):e010816. doi: 10.1136/bmjopen-2015-010816.